Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S Maintenance Therapy Compared to Best Available Therapy in Acute Myeloid Leukemia Patients Who Have Achieved Complete Remission After Second-Line Salvage Therapy
- 0034 923 291 100 ext. 56751 (secretaria)
- hemasecre.husa@saludcastillayleon.es
- Paseo de la Transición, s/n. Salamanca